Evidence map›Paper›PMID 42733635›Full record

ArticleJournal of inflammation research2026

Pseudo-Pseudo Meigs' Syndrome-Like Presentation Associated with Primary Sjögren's Syndrome: A Case Report.

Jixiang Xun, Xiaohan Liu, Bohan Chang, Xue Wang, Cheng Peng, Pingting Yang, Xudong Liu

Abstract readCase Reports
In one paragraph

Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jixiang Xun *Department of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Xiaohan Liu *Department of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Bohan Chang *Department of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Xue WangDepartment of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Cheng PengDepartment of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Pingting YangDepartment of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Xudong LiuDepartment of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.ORCID 0000-0002-0694-3005

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore the clinical diagnostic methods and therapeutic outcomes for rheumatologic and immunologic disorders characterized by "polypleural effusion with elevated CA12-5", aiming to avoid misdiagnosis and mistreatment due to similar symptoms. Methods: A retrospective analysis was conducted on the clinical data of a 56-year-old female patient. Multidisciplinary consultation (gynecology, thoracic medicine, rheumatology and immunology), imaging studies, laboratory tests, and pathological biopsy results were combined to establish a definitive diagnosis. After diagnosis, the patient received combined treatment with corticosteroids and immunosuppressants, with dynamic evaluation of clinical efficacy. Results: Systematic examinations ruled out gynecological tumors, tuberculosis, and other diseases. Based on abnormal rheumatologic and immunologic markers, organ involvement, and treatment response, the patient was diagnosed with primary Sjögren's syndrome, pseudo-pseudo Meigs' syndrome (PPMS,Tjalma syndrome), interstitial pneumonia and so on. After treatment with methylprednisolone combined with hydroxychloroquine and mycophenolate mofetil, CA12-5 levels significantly decreased, polypleural effusion gradually resolved, and the condition remained stable over the long term. Conclusion: Primary Sjögren's syndrome may be complicated by PPMS, with PPMS as the initial clinical manifestation. Early multidisciplinary collaboration is crucial to avoid misdiagnosis, and the corticosteroid combined with immunosuppressant treatment has been proved that it was associated with clinical improvement.

Indexed as

CA12-5immunosuppressantspleural effusionpseudomegaly syndromeSjögren’s syndrome

Identifiers

PMID42733635
PMCPMC13571668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.